- Nextleaf Labs, a subsidiary of Nextleaf Solutions (OILS), has received an amendment to its existing Cannabis Research License from Health Canada
- The amendment allows the company to conduct controlled human administration trials for the sensory evaluation of cannabis
- Under the research license, Nextleaf Labs can begin comprehensively testing cannabis vape oils for key fluid parameters such as viscosity
- The company said it plans to use this license to conduct controlled human trials for the sensory evaluation of Rapid Emulsion Technology by OILS
- Nextleaf Solutions is up 11.48 per cent to C$0.34 per share
Nextleaf Labs, a subsidiary of Nextleaf Solutions (OILS), has received an amendment to its existing Cannabis Research License from Health Canada.
The amendment allows the company to conduct controlled human administration trials for the sensory evaluation of cannabis.
Nextleaf Labs will conduct the trials at its processing facility in Metro Vancouver.
The licence permits Nextleaf Labs to conduct R&D involving the administration of cannabis to human subjects for the assessment of taste, sight, or smell, subject to conditions laid out by Health Canada.
Nextleaf CEO Paul Pedersen said sensory evaluation with human subjects is essential to the development of differentiated cannabis 2.0 products.
“We believe this license provides added-value to consumer-packaged goods companies looking for product development and formulation capabilities within a federally legal market,” Pederson said.
In a press release, the company said it plans to use this license to conduct controlled human trials for the sensory evaluation of Rapid Emulsion Technology by OILS, the company’s proprietary water-soluble emulsion technology for cannabis infused products.
The license will allow the company to conduct focus-group studies to provide its commercial partners with data, based on consumer feedback around taste and overall user experience.
Under the research license, Nextleaf Labs can begin comprehensively testing cannabis vape oils for key fluid parameters such as viscosity, and how various oil formulations interact with different vape hardware to determine the best fit for each partners’ formulations.
The company expects to drastically shorten design cycles and accelerate product development by validating new technologies and formulations more efficiently.
Nextleaf Solutions is up 11.48 per cent to C$0.34 per share at 2:22pm EST.